Company intelligence / Profile preview

CandorPharm

Montreal, Quebec, Canadacandorpharm.com ↗

Ownership: Private
Development stage: Other

Overview

CandorPharm markets approved and commercialized products in Canada, particularly in ophthalmology through its division Candorvision. The company focuses on innovative and preservative-free eye care products and has received a Medical Device Establishment License from Health Canada. No clinical trial data or investigational programs are reported; the company operates at the commercial stage with licensed and registered products.[1][6]

Therapeutic areas: DermatologyOphthalmologyPulmonologyWomen's Health
Modalities: Small molecule (pharmaceuticals)Medical device (medical devices)Cosmetic product (cosmetics)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on CandorPharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CandorPharm.

Explore the full profile